VAERS Explorer
Back to explore

Report #2888946

Received Mar 14, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
57 yrs
State
TX
Recovered
Not recovered
Vaccinated
Mar 5, 2026
Onset
Mar 5, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.N/AZ010457IM / LA
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1CH929IM / LA

Symptoms (10)

HeadacheImmediate post-injection reactionImpaired work abilityInjection site erythemaInjection site painInjection site pruritusInjection site rashInjection site reactionLethargySkin exfoliation

Symptom narrative

PT STATES IMMEDIATE BURNING SENSATION AT ADMINISTRATION. AT 24 HOURS - LOCAL REDNESS AND HIVE-LIKE RASH. AT 48-72 HOURS - BULLSEYE RASH, ITCHING, REDNESS FROM INJ SITE TO ELBOW, HEADACHE, LETHARGY. 96 HOURS - CONTINUATION OF PREVIOUS SYMPTOMS, SKIN AT INJ SITE BEGAN TO PEEL, PT MISSED WORK.

Current illness

N/A

Medical history

BERTOLOTTI'S SYNDROME, OA, GAD, DEPRESSION, PROLONGED GRIEF DISORDER

Other medications

BUSPIRONE, TOPIRAMATE, PROGESTERONE, BUPRENORPHINE, TRAMADOL, PREGABALIN, DULOXETINE

Allergies

NKDA